NLRP3 and sarcopenia: The NLRP3 inflammatory pathway was already reported to be involved in cardiac remodeling during pressure overload in an NLRP3 KO mouse model and resulted in reduced sarcopenia onset and progression, loss of muscle glycolytic potential, and mitochondrial dysfunction [52,53].